US$ 29.73
constipation from tirzepatide How to manage while taking tirzepatide? What is a suitable bowel
Description
doi: 10.1093/infdis/121.2.124
The initial GLP-1 agonist based on Gila monster venom was approved to treat diabetes in 2005
Semaglutide slows gastric emptying as part of its appetite-suppressing mechanism, which can trigger constipation in up to 26% of clinical trial participants

This is legal with a prescription but exists in a regulatory grey area because retatrutide is not FDA-approved and is not on the FDA drug shortage list (unlike semaglutide and tirzepatide have been)
